These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 26218904)

  • 1. M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
    Zhou Y; Yoshida S; Nakao S; Yoshimura T; Kobayashi Y; Nakama T; Kubo Y; Miyawaki K; Yamaguchi M; Ishikawa K; Oshima Y; Akashi K; Ishibashi T
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4767-77. PubMed ID: 26218904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages promote vasculogenesis of retinal neovascularization in an oxygen-induced retinopathy model in mice.
    Gao X; Wang YS; Li XQ; Hou HY; Su JB; Yao LB; Zhang J
    Cell Tissue Res; 2016 Jun; 364(3):599-610. PubMed ID: 26841878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of vitreal macrophages and circulating leukocytes in retinal neovascularization.
    Kataoka K; Nishiguchi KM; Kaneko H; van Rooijen N; Kachi S; Terasaki H
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1431-8. PubMed ID: 21051720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).
    Scott A; Powner MB; Fruttiger M
    Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial distribution of CD115
    Brockmann C; Dege S; Crespo-Garcia S; Kociok N; Brockmann T; Strauß O; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):313-323. PubMed ID: 29185100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased retinal neovascularization in Fas ligand-deficient mice.
    Davies MH; Eubanks JP; Powers MR
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model.
    Liu X; Wang D; Liu Y; Luo Y; Ma W; Xiao W; Yu Q
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary study of retinal pathological features in preterm birth pups exposed to an animal model of oxygen-induced retinopathy in mice.
    Chu ZJ; Dou GR; Wang YS; Qu XJ; Zhang Y
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1937-43. PubMed ID: 23740517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
    Fang X; Ueno M; Yamashita T; Ikuno Y
    Curr Eye Res; 2011 Nov; 36(11):1028-36. PubMed ID: 21999228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of 15-lipoxygenase-1 in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via downregulation of vascular endothelial growth factor-A expression.
    Li Z; He T; Du K; Xing YQ; Yan Y; Chen Z; Zhang H; Shen Y
    Mol Vis; 2012; 18():2847-59. PubMed ID: 23233787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-19 Promotes Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy.
    Zou J; Tan W; Li B; Wang Z; Li Y; Zeng J; Jiang B; Yoshida S; Zhou Y
    Invest Ophthalmol Vis Sci; 2022 Jul; 63(8):9. PubMed ID: 35816041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression.
    Cheng G; Tian K; Zhang L; Yang N; Xing Y; He T
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):97-108. PubMed ID: 26358273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
    Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
    Kociok N; Krohne TU; Poulaki V; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
    Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.